Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Locarnini

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore proteinKumar Visvanathan, Narelle A Skinner, Alex J V Thompson, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
Gastroenterology|June 9, 2005
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapyJoseph J Y Sung, May-Ling Wong, Scott Bowden, et al.
Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
International Journal for Equity in Health|December 27, 2022
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
Antiviral Therapy|September 16, 2014
Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutationsAmanda L Aloia, Nicholas S Eyre, Stuart Black, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore proteinKumar Visvanathan, Narelle A Skinner, Alex J V Thompson, et al.
AIDS (London, England)|July 9, 2009
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individualsGail V Matthews, Eric Seaberg, Gregory J Dore, et al.
Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
Gastroenterology|June 9, 2005
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapyJoseph J Y Sung, May-Ling Wong, Scott Bowden, et al.
Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
AIDS (London, England)|March 8, 2016
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversityJennifer Audsley, Stephen J Bent, Margaret Littlejohn, et al.
International Journal for Equity in Health|December 27, 2022
Preventing early childhood transmission of hepatitis B in remote aboriginal communities in Northern AustraliaRichard P Sullivan, Jane Davies, Paula Binks, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandGail V Matthews, Anchalee Avihingsanon, Sharon R Lewin, et al.
Antiviral Therapy|September 16, 2014
Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutationsAmanda L Aloia, Nicholas S Eyre, Stuart Black, et al.
Pageof 14